Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS) SHH

38.10

-2.19(-5.44%)

Updated at April 23 03:00PM

Currency In CNY

Valuation

Market Cap15.36B
Enterprise Value16.8B
P/E Ratio-15.77
PEG Ratio-4.93
Price/Sales Ratio22.98
Price/Book Ratio43.79
Enterprise/Revenue25.16
Enterprise/EBITDA-19.37

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin-1.46
Operating Margin-1.44

Management Effectiveness

Return On Assets-0.21
Return On Equity-1.21

Income Statement

Revenue662.52M
Revenue/Share1.65
Gross Profit662.52M
EBITDA-860.38M
Net Income-970.18M
Diluted EPS-2.43

Balance Sheet

Total Cash1.53B
Total Cash/Share3.8
Total Debt2.97B
Total Debt/Equity8.5
Current Ratio0.9
Book Value Per Share1.33

Price History

52-Week Change78.79
52-Week High63.59
52-Week Low16.78
Moving Average 50 Days35.83
Moving Average 200 Days40.73

Statistics

Average Volume7.55M
Shares Outstanding399.6M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.04
Last Split FactorN/A
Last Split DateN/A